The PFS results were in conjunction with a prolonged duration of response. In sufferers with EGFRm T790M+ advanced NSCLC treated at the 80 mg dose, the preliminary median duration of response was 8.2 months. James Chih-Hsin Yang, MD, PhD, professor of Graduate Institute of Director and Oncology of Cancer Research Center at National Taiwan University University of Medicine, said: We are optimistic and encouraged by the prices of progression free survival and period of response results in sufferers treated with AZD9291. As the data are immature still, they derive from robust patient numbers which give us self-confidence that is a pattern which will continue. To date, the longest duration of response is ongoing at more than 11 months still. The confirmed general response rate for sufferers with EGFRm T790M+ advanced NSCLC treated at the 80 mg dosage was 70 %.The supplements increased vitamin D from insufficient to sufficient levels in every but one senior who received the supplements, and to optimal levels in every but five. Also, seniors who received the vitamin D supplements reported about 50 percent the falls as those in the placebo group, according to the research published online Aug. 16 in the Journal of the American Geriatrics Society. However, the study doesn’t actually prove that higher levels of the vitamin avoided falls. ‘Although these initial findings are encouraging, we need to confirm the results in a more substantial trial,’ Houston said in a Wake Forest news release.